MWA
BSX icon

Medallion Wealth Advisors’s Boston Scientific BSX Stock Holding History

Medallion Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$1.13K – 1229
2026
Q1 		$1.13K Sell
18
-24
-57% -$1.92K ﹤0.01% 1051
2025
Q4 		$4K Hold
42
– – ﹤0.01% 903
2025
Q3 		$4.1K Hold
42
– – ﹤0.01% 885
2025
Q2 		$4.4K Hold
42
– – ﹤0.01% 852
2025
Q1 		$4.25K Hold
42
– – ﹤0.01% 813
2024
Q4 		$3.75K Buy
+42
New +$3.7K ﹤0.01% 777

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Medallion Wealth Advisors's BSX Position: Q2 2026 in Review

Medallion Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 18 shares — an estimated $1.13K sold.

Medallion Wealth Advisors first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $4.4K in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Medallion Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Medallion Wealth Advisors sold 18 Boston Scientific shares in Q2 2026, an estimated $1.13K.
  • Medallion Wealth Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Medallion Wealth Advisors's Boston Scientific position peaked at $4.4K in Q2 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.